Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed outlook with both positive and negative elements. While there are promising growth opportunities in international markets and defense programs, the company has revised its revenue guidance downwards and faces uncertainties in contract timing and financial impacts. The Q&A reveals concerns about specific program timelines and financial projections, which could create investor caution. The lack of clear guidance for 2026 and beyond, coupled with no immediate plans for share buybacks, further tempers enthusiasm. Overall, these factors suggest a neutral stock price movement over the next two weeks.
Backlog Over $95 billion, a new company record, driven by over $46 billion in net awards in 2025. Backlog has grown by nearly $20 billion since 2021. This growth is attributed to strong demand and successful contract awards.
Free Cash Flow $3.3 billion for 2025, representing a 26% increase compared to 2024. This marks the third consecutive year of at least 25% growth, driven by strong operational performance and increased demand.
Fourth Quarter Sales $11.7 billion, up 10% compared to the prior year. Growth was driven by material timing on the F-35 program, continued ramp on TACAMO, and higher volume on the B-21 program.
Aeronautics Systems Sales $3.9 billion in Q4, up 18% compared to the prior year. Growth was driven by material timing on the F-35 program, continued ramp on TACAMO, and higher volume on the B-21 program.
Defense Systems Sales Grew by 7% on a GAAP basis and 12% organically in Q4. Growth was driven by higher volume in solid rocket motors, missile defense portfolio, and the Sentinel program.
Mission Systems Sales Achieved double-digit growth in Q4, driven by strong production volume on restricted programs, F-35, SEWIP, and international radar systems.
Space Segment Sales Up 5% in Q4 compared to the prior year. Growth was driven by increased production of GEM 63 motors for Amazon's project Leo and increased volume on certain restricted programs.
2025 Total Sales $42 billion, up 3% organically compared to the prior year. Growth was attributed to strong demand and disciplined execution.
Segment Operating Income Up 10% year-over-year in Q4, with a segment operating margin rate of 11.2%. Growth was driven by higher sales volume and sound program execution.
Aeronautics Systems Operating Income Increased by 20% in Q4, driven by higher sales volume and sound program execution.
Space Segment Operating Income Up 17% in Q4, with an operating margin rate of 11.3%. Growth was driven by higher net EAC adjustments and a more favorable contract mix.
Earnings Per Share (EPS) $7.23 in Q4, up 13% compared to the prior year. Growth was driven by higher sales and strong segment performance.
High-volume space assets: Awarded for 18 Tranche 3 Tracking Layer satellites, bringing total SDA satellite backlog to 150. These assets provide global detection, warning, and tracking of hypersonic weapons and advanced missiles.
Project Talon: An uncrewed combat aircraft designed and built in under 24 months, leveraging the Talon IQ ecosystem. Received designation YFQ-48A from the U.S. Air Force.
Collaborative combat aircraft for the Marine: Teamed with Kratos to develop an uncrewed aircraft, receiving a $231 million award. Completed over 20 successful demonstrations.
International sales growth: International sales grew by 20% in 2025, driven by demand for air and missile defense systems, advanced munitions, radars, and airborne capabilities. Formal requests for IBCS received from over 20 countries.
Global demand for radars: Contracts expected from customers in the Americas, Middle East, and Asia Pacific for ground-based radars.
Munitions production capacity: Doubled production capacity for tactical solid rocket motors at the ABL facility since 2021, with plans to triple capacity by 2027. Similar investments at Elkton, Maryland, to triple capacity by 2030.
Segment performance: Aeronautics Systems grew 18% in Q4 2025, driven by programs like F-35, TACAMO, and B-21. Space segment sales increased by 5% in Q4, supported by GEM 63 motors and restricted programs.
Strategic deterrence assets: Progress on B-21 program with key milestones, including first flight of the second aircraft in 2025. Awarded LRIP Lot 3 contract and advanced procurement funding for Lot 5.
Sentinel program: Advancing missile development, launch silo design, and prototyping activities in command and launch segments.
Regulatory and Bureaucratic Challenges: The company faces challenges in breaking down bureaucracy and increasing delivery speeds for capabilities, as highlighted by the need to move beyond traditional business models and partner more effectively with customers.
Supply Chain and Production Capacity: Efforts to scale operations and expand production capacity for munitions and other critical areas indicate potential risks in meeting rapidly increasing demand. For example, the company is working to triple production capacity for tactical solid rocket motors by 2027 and 2030 at different facilities.
Program Execution Risks: The company is involved in complex programs like the B-21 and Sentinel, which require restructuring and accelerated production. These programs carry risks related to meeting milestones, cost overruns, and maintaining quality.
Economic and Budgetary Uncertainties: The company’s reliance on defense appropriations and reconciliation investments, which are subject to political and economic uncertainties, poses a risk to its financial stability and growth.
International Market Risks: While international sales are growing, the company faces risks related to forming industrial partnerships and navigating regulatory environments in different countries.
Revenue Expectations: For 2026, Northrop Grumman expects sales to be between $43.5 billion and $44 billion, representing mid-single-digit growth. Growth is supported by strength across all four business segments.
Segment Performance: Aeronautics Systems (AS) sales are expected to grow to mid-$13 billion, driven by increased volume on programs like B-21 and TACAMO. Defense Systems (DS) sales are projected to rise in the low double digits organically to the mid to high $8 billion range, driven by strong demand across weapons, missile defense, and strategic deterrence programs. Mission Systems (MS) sales are expected to reach the high $12 billion range, with broad-based demand across their portfolio. Space segment sales are projected to grow to approximately $11 billion, driven by restricted space and missile defense programs.
Margin Projections: Segment operating income for 2026 is projected to be between $4.85 billion and $5 billion, with a low to mid-11% segment operating margin. Margins for Aeronautics Systems are expected to be low to mid 9%, Defense Systems around 10%, Mission Systems in the high 14% range, and Space segment at approximately 11%.
Capital Expenditures: Capital expenditures for 2026 are projected to be $1.65 billion, approximately 4% of total sales. This increase is based on the strong demand environment and aims to enhance production capacity and support the industrial base.
Free Cash Flow: Free cash flow for 2026 is estimated to be between $3.1 billion and $3.5 billion, offsetting higher capital spend with strong operational cash flows.
Market Trends and Demand: The company anticipates continued strong demand in 2026 and beyond, particularly in air and missile defense systems, advanced munitions, radars, and airborne capabilities. International sales grew by 20% in 2025, and demand signals remain strong globally.
Strategic Programs and Investments: Northrop Grumman is making significant investments to expand production capacity for tactical solid rocket motors and other critical areas. The company is also advancing key programs like B-21, Sentinel, and restricted space programs, with plans to accelerate B-21 production rates pending agreement with the Air Force.
The selected topic was not discussed during the call.
The earnings call presents a mixed outlook with both positive and negative elements. While there are promising growth opportunities in international markets and defense programs, the company has revised its revenue guidance downwards and faces uncertainties in contract timing and financial impacts. The Q&A reveals concerns about specific program timelines and financial projections, which could create investor caution. The lack of clear guidance for 2026 and beyond, coupled with no immediate plans for share buybacks, further tempers enthusiasm. Overall, these factors suggest a neutral stock price movement over the next two weeks.
The earnings call summary and Q&A indicate strong revenue growth, solid international sales, and promising program developments like B-21 and Golden Dome. Despite some unclear management responses, the overall sentiment is positive due to increased free cash flow guidance, robust defense investments, and capacity expansion plans. These factors, along with optimistic guidance and strong financial metrics, suggest a potential positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.